Nomura Holdings
IMUC

Nomura Holdings’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Nomura Holdings’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-554
Closed -$5K – 1578
2016
Q2 		$5K Buy
+554
New +$5.7K ﹤0.01% 1213
2015
Q2 		– Sell
-2,650
Closed -$60K – 2292
2015
Q1 		$60K Buy
+2,650
New +$66.5K ﹤0.01% 1638
2014
Q4 		– Sell
-13
Closed – – 3152
2014
Q3 		$0 Buy
+13
New +$501 ﹤0.01% 3388
2014
Q1 		– Sell
-993
Closed -$37K – 3131
2013
Q4 		$37K Buy
+993
New +$94.1K ﹤0.01% 1905

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.6B AUM 27.3% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return